Skip to main content
Veterinary Medicines

LABIASOL AD3E-500, (500+75+50)IU/ML ενέσιμο εναιώρημα για ιπποειδή, βοοειδή, πρόβατα, αίγες και χοίρους

Authorised
  • Retinol
  • Colecalciferol
  • DL-ALPHA-TOCOPHEROL

Product identification

Medicine name:
LABIASOL AD3E-500, (500+75+50)IU/ML ενέσιμο εναιώρημα για ιπποειδή, βοοειδή, πρόβατα, αίγες και χοίρους
Active substance:
  • Retinol
  • Colecalciferol
  • DL-ALPHA-TOCOPHEROL
Target species:
  • Cattle
  • Sheep
  • Goat
  • Pig
  • Horse
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Retinol
    500000.00
    international unit(s)
    /
    1.00
    millilitre(s)
  • Colecalciferol
    75000.00
    international unit(s)
    /
    1.00
    millilitre(s)
  • DL-ALPHA-TOCOPHEROL
    50.00
    international unit(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • Meat and offal
        280
        day
      • Milk
        120
        hour
    • Sheep
      • Meat and offal
        243
        day
      • Milk
        120
        hour
    • Goat
      • Meat and offal
        243
        day
      • Milk
        120
        hour
    • Pig
      • Meat and offal
        259
        day
    • Horse
      • Meat and offal
        280
        day
      • Milk
        120
        hour
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QA11A
Authorisation status:
  • Valid
Authorised in:
  • Greece
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Hellafarm S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Labiana Life Sciences S.A.
Responsible authority:
  • National Organization For Medicines
Authorisation number:
  • 7761/17-03-1993/K-0071001
Date of authorisation status change:
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."